Abstract
Findings from a simulated pancreatic cancer trial indicate that some common eligibility criteria, including infectious comorbidities, disproportionately disqualify more Black than white patients from being enrolled. The researchers proposed alternative criteria, showing that the changes could eliminate the imbalance in eligibility.
©2021 American Association for Cancer Research.
2021
American Association for Cancer Research.
You do not currently have access to this content.